Grapefruit-Drug Interactions
暂无分享,去创建一个
Laura Dickinson | David Back | Saye Khoo | K. Seden | S. Khoo | D. Back | L. Dickinson | Kay Seden
[1] P. Watkins,et al. PHARMACOKINETICS AND DRUG DISPOSITION Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins , 2001 .
[2] R. Kim,et al. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. , 2006, British journal of clinical pharmacology.
[3] Y. Sawada,et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects , 2000, Clinical pharmacology and therapeutics.
[4] S. E. Rau,et al. Grapefruit juice—terfenadine single‐dose interaction: Magnitude, mechanism, and relevance , 1997, Clinical pharmacology and therapeutics.
[5] W. Tassaneeyakul,et al. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. , 2000, British journal of clinical pharmacology.
[6] T. Rundlöf,et al. Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy , 2007, European Journal of Clinical Pharmacology.
[7] S. Preskorn,et al. Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors , 1997, Clinical pharmacokinetics.
[8] B. Pollock,et al. Newer antidepressants and the cytochrome P450 system. , 1996, The American journal of psychiatry.
[9] H. Dieperink,et al. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] S. Masuda,et al. Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. , 2006, Drug metabolism and pharmacokinetics.
[11] B. Patil,et al. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. , 2007, Journal of food science.
[12] G. Muirhead,et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.
[13] A. B. Prasad,et al. British National Formulary , 1994 .
[14] R. Woestenborghs,et al. The Clinical Pharmacokinetics of Itraconazole: An Overview , 1989, Mycoses.
[15] S. Kaneko,et al. Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin. , 2005, British journal of clinical pharmacology.
[16] R. Obach,et al. SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY , 2005, Drug Metabolism and Disposition.
[17] S. Vandel,et al. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice , 2000, European Journal of Clinical Pharmacology.
[18] M. Jann,et al. Effect of Seville Orange Juice and Grapefruit Juice on Indinavir Pharmacokinetics , 2002, Journal of clinical pharmacology.
[19] U. Fuhr,et al. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. , 1993, British journal of clinical pharmacology.
[20] U. Fuhr,et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil , 2002, Clinical pharmacology and therapeutics.
[21] G R Wilkinson,et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[22] P. Watkins,et al. Two Major Grapefruit Juice Components Differ in Time to Onset of Intestinal CYP3A4 Inhibition , 2005, Journal of Pharmacology and Experimental Therapeutics.
[23] C. Eap,et al. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone , 2004, Clinical pharmacology and therapeutics.
[24] M. Ducharme,et al. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice , 1995, Clinical pharmacology and therapeutics.
[25] I. Wainer,et al. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. , 2002, Life sciences.
[26] D. M. Sullivan,et al. Grapefruit juice and the response to warfarin. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[27] P. Neuvonen,et al. Grapefruit juice enhances the exposure to oral oxycodone. , 2010, Basic & clinical pharmacology & toxicology.
[28] P. Neuvonen,et al. Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. , 2007, British journal of clinical pharmacology.
[29] R. Kim,et al. Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides , 2005, Clinical pharmacology and therapeutics.
[30] P. Neuvonen,et al. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174 , 1998, European Journal of Clinical Pharmacology.
[31] P. Ho,et al. Grapefruit juice has no effect on quinine pharmacokinetics , 1999, European Journal of Clinical Pharmacology.
[32] A. Åsberg,et al. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers , 2002, European Journal of Clinical Pharmacology.
[33] T. Tsuruo,et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. , 2000, Cancer letters.
[34] G. Dresser,et al. Grapefruit‐felodipine interaction: Effect of unprocessed fruit and probable active ingredients , 2000, Clinical pharmacology and therapeutics.
[35] U. Fuhr,et al. Lacking effect of grapefruit juice on theophylline pharmacokinetics. , 1995, International journal of clinical pharmacology and therapeutics.
[36] D. Bailey,et al. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics , 1993, Clinical pharmacology and therapeutics.
[37] K. Rieckmann,et al. Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? , 2006, British journal of clinical pharmacology.
[38] C. Funck-Brentano,et al. Effect of grapefruit juice on digoxin pharmacokinetics in humans , 2001, Clinical pharmacology and therapeutics.
[39] M. Odomi,et al. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms , 2000, Human & experimental toxicology.
[40] K. He,et al. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. , 1998, Chemical research in toxicology.
[41] Eiji Uchida,et al. Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. , 2004, British journal of clinical pharmacology.
[42] P. Neuvonen,et al. Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin , 2008, Clinical pharmacokinetics.
[43] P. Neuvonen,et al. Grapefruit juice—simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG‐CoA reductase inhibitors , 1998, Clinical pharmacology and therapeutics.
[44] D. Lowenthal,et al. Effect of grapefruit juice on blood cyclosporin concentration , 1995, The Lancet.
[45] S. Garg,et al. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy , 1998, Clinical pharmacology and therapeutics.
[46] R. Yoshimura,et al. Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[47] P. Callery,et al. Esterase Inhibition Attribute of Grapefruit Juice Leading to a New Drug Interaction , 2007, Drug Metabolism and Disposition.
[48] A. Taburet,et al. Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice , 2002, Antimicrobial Agents and Chemotherapy.
[49] Y. Sawada,et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3 , 2007, Biopharmaceutics & drug disposition.
[50] A. Harralson,et al. The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study. , 1999, Clinical therapeutics.
[51] A. Fujimura,et al. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam , 2004 .
[52] E. Lentjes,et al. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients , 1995, Clinical pharmacology and therapeutics.
[53] H. Gilles,et al. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. , 1985, Annals of tropical medicine and parasitology.
[54] P. Neuvonen,et al. Effects of grapefruit juice on the absorption of levothyroxine. , 2005, British journal of clinical pharmacology.
[55] N. Benowitz,et al. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance , 2006, Clinical pharmacology and therapeutics.
[56] T. Uno,et al. Lack of Significant Effect of Grapefruit Juice on the Pharmacokinetics of Lansoprazole and Its Metabolites in Subjects With Different CYP2C19 Genotypes , 2005, Journal of clinical pharmacology.
[57] J. Bend,et al. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. , 1995, British journal of clinical pharmacology.
[58] G. Moore. Oranges and lemons: clues to the taxonomy of Citrus from molecular markers. , 2001, Trends in genetics : TIG.
[59] K. Otani,et al. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice. , 1999, International clinical psychopharmacology.
[60] J. Kapelushnik,et al. Near fatal acute colchicine intoxication in a child. A case report , 2000, European Journal of Pediatrics.
[61] A. Mehrsai,et al. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients. , 2003, Transplantation proceedings.
[62] C. Regårdh,et al. Felodipine kinetics in healthy men , 1985, Clinical pharmacology and therapeutics.
[63] J. Ahlner,et al. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers , 1996, European Journal of Clinical Pharmacology.
[64] F. Gmitter. Origin, Evolution, and Breeding of the Grapefruit , 2010 .
[65] D. Sica. Interaction of grapefruit juice and calcium channel blockers. , 2006, American journal of hypertension.
[66] P. Watkins,et al. TWO MAJOR GRAPEFRUIT JUICE COMPONENTS DIFFER IN INTESTINAL CYP3A4 INHIBITION KINETIC AND BINDING PROPERTIES , 2004, Drug Metabolism and Disposition.
[67] D. Bailey,et al. Interaction of citrus juices with felodipine and nifedipine , 1991, The Lancet.
[68] D. K. Williams,et al. Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice , 2008, European Journal of Clinical Pharmacology.
[69] Morton B. Brown,et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. , 1997, The Journal of clinical investigation.
[70] T. Abe,et al. Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. , 2001, Endocrinology.
[71] P. Neuvonen,et al. Grapefruit juice substantially increases plasma concentrations of buspirone , 1998, Clinical pharmacology and therapeutics.
[72] E. Scapa,et al. Effect of Grapefruit Juice on the Pharmacokinetics of Losartan and Its Active Metabolite E3174 in Healthy Volunteers , 2001, Therapeutic drug monitoring.
[73] P. Neuvonen,et al. Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. , 2004, British journal of clinical pharmacology.
[74] F. Halaweish,et al. NARINGIN DOES NOT ALTER CAFFEINE PHARMACOKINETICS, ENERGY EXPENDITURE, OR CARDIOVASCULAR HAEMODYNAMICS IN HUMANS FOLLOWING CAFFEINE CONSUMPTION , 2006, Clinical and experimental pharmacology & physiology.
[75] R. Mayol,et al. The relationship between buspirone bioavailability and dose in healthy subjects. , 1985, Biopharmaceutics & drug disposition.
[76] M. Agtmael,et al. The effect of grapefruit juice on the time‐dependent decline of artemether plasma levels in healthy subjects , 1999, Clinical pharmacology and therapeutics.
[77] P. Neuvonen,et al. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole , 1998, Clinical pharmacology and therapeutics.
[78] J. Lin,et al. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. , 1997, Biochemical pharmacology.
[79] J. Fourie,et al. Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C → A Polymorphism in Intron 1 of the CYP1A2 Gene: Effect of Grapefruit Juice and Low-Dose Fluvoxamine , 2001, Journal of clinical psychopharmacology.
[80] Y. Sawada,et al. CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2005, Drug Metabolism and Disposition.
[81] S. Soback,et al. The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil , 1998, European Journal of Clinical Pharmacology.
[82] S. Mertens-Talcott,et al. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. , 2007, Journal of pharmaceutical sciences.
[83] J. Mendels,et al. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo , 1995, Biological Psychiatry.
[84] P. Watkins,et al. 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein , 1999, Clinical pharmacology and therapeutics.
[85] M. Endres,et al. Statin-associated rhabdomyolysis triggered by grapefruit consumption , 2004, Neurology.
[86] P. Neuvonen,et al. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole , 2002, Clinical pharmacology and therapeutics.
[87] P. Woster,et al. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[88] P. Neuvonen,et al. Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride , 1999, Clinical pharmacology and therapeutics.
[89] Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine. , 1993, British journal of clinical pharmacology.
[90] C. Peloquin,et al. Effect of Grapefruit Juice on Clarithromycin Pharmacokinetics , 1998, Antimicrobial Agents and Chemotherapy.
[91] R. Benton,et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.
[92] R. B. Parker,et al. Effects of Grapefruit Juice on Intestinal P‐glycoprotein: Evaluation Using Digoxin in Humans , 2003, Pharmacotherapy.
[93] Samir K. Gupta,et al. Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine , 2002, Clinical pharmacokinetics.
[94] Y. Kato,et al. Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. , 2009, Journal of pharmaceutical sciences.
[95] M. Ducharme,et al. Trough concentrations of cyclosporine in blood following administration with grapefruit juice. , 1993, British journal of clinical pharmacology.
[96] A. Y. Lu,et al. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. , 2001, Annual review of pharmacology and toxicology.
[97] P. Ho,et al. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers , 2000, European Journal of Clinical Pharmacology.
[98] K. Brøsen,et al. The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide. , 2006, British journal of clinical pharmacology.
[99] H. McLeod,et al. Effect of grapefruit juice intake on etoposide bioavailability , 2002, European Journal of Clinical Pharmacology.
[100] P. Neuvonen,et al. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid , 1998, Clinical pharmacology and therapeutics.
[101] J. Sotelo,et al. Interaction between Grapefruit Juice and Praziquantel in Humans , 2002, Antimicrobial Agents and Chemotherapy.
[102] G. Dresser,et al. Grapefruit juice–felodipine interaction in the elderly , 2000, Clinical pharmacology and therapeutics.
[103] S. Larsen,et al. Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice. , 2002, British journal of clinical pharmacology.
[104] R. Deane,et al. Thyroxine (T4) transfer from CSF to choroid plexus and ventricular brain regions in rabbit: Contributory role of P-glycoprotein and organic anion transporting polypeptides , 2007, Brain Research.
[105] P. Neuvonen,et al. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole , 1998, European Journal of Clinical Pharmacology.
[106] P. Watkins,et al. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. , 2006, The American journal of clinical nutrition.
[107] M. Shelton,et al. Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV‐Positive Subjects , 2001, Journal of clinical pharmacology.
[108] G. Foulds,et al. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. , 2000, British journal of clinical pharmacology.
[109] P. Neuvonen,et al. Grapefruit juice can increase the plasma concentrations of oral methylprednisolone , 2000, European Journal of Clinical Pharmacology.
[110] P. Watkins,et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[111] Y. Sawada,et al. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. , 1998, Biological & pharmaceutical bulletin.
[112] P. Neuvonen,et al. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal‐suppressant effect , 2000, Clinical pharmacology and therapeutics.
[113] Zheng Wu,et al. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study , 2009, European Journal of Clinical Pharmacology.
[114] G. Dresser,et al. Interactions Between Grapefruit Juice and Cardiovascular Drugs , 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[115] D. Schrenk,et al. Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. , 2005, Biochemical pharmacology.
[116] I. Zadezensky,et al. Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided? , 2006, Journal of clinical pharmacology.
[117] P. Neuvonen,et al. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin , 1999, Clinical pharmacology and therapeutics.
[118] Y. Oshima,et al. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. , 1997, Pharmacogenetics.
[119] L. Bertilsson,et al. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. , 2003, British journal of clinical pharmacology.
[120] C. Regårdh,et al. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects , 2004, European Journal of Clinical Pharmacology.
[121] Y. Sawada,et al. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. , 2000, The Journal of pharmacology and experimental therapeutics.
[122] T. Ishizaki,et al. Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site , 2000, European Journal of Clinical Pharmacology.
[123] P. Neuvonen,et al. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol , 2003, Clinical pharmacology and therapeutics.
[124] A. Olyaei,et al. Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients , 2000, Pediatric transplantation.
[125] Á. Balogh,et al. Can grapefruit juice influence ethinylestradiol bioavailability? , 1996, Contraception.
[126] W. Kirch,et al. Pharmacokinetics and Pharmacodynamics in Clinical Use of Scopolamine , 2005, Therapeutic drug monitoring.
[127] U. Fuhr,et al. Effects of grapefruit juice and smoking on verapamil concentrations in steady state , 2002, European Journal of Clinical Pharmacology.
[128] J. Vanakoski,et al. PHARMACOKINETICS AND DISPOSITION , 2022 .
[129] E. Nicolosi,et al. Citrus phylogeny and genetic origin of important species as investigated by molecular markers , 2000, Theoretical and Applied Genetics.
[130] T. Terao,et al. Grapefruit Juice-fluvoxamine Interaction: Is It Risky Or Not? , 2003, Journal of clinical psychopharmacology.
[131] P. Chakravarty,et al. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[132] S. Krähenbühl,et al. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. , 1998, British journal of clinical pharmacology.
[133] B. Marston,et al. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine , 2001, AIDS.
[134] N. Gallagher,et al. Effect of Grapefruit Juice on the Pharmacokinetics of Nilotinib in Healthy Participants , 2010, Journal of clinical pharmacology.
[135] M. Niemi,et al. Grapefruit Juice Greatly Reduces the Plasma Concentrations of the OATP2B1 and CYP3A4 Substrate Aliskiren , 2010, Clinical pharmacology and therapeutics.
[136] T. Hedner,et al. Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. , 1994, Maturitas.
[137] D. Edwards,et al. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. , 1996, Life sciences.
[138] C. Libersa,et al. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. , 2000, British journal of clinical pharmacology.
[139] G. Amidon,et al. Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein , 2009, Pharmaceutical Research.
[140] C. Barthélémy,et al. Grapefruit juice–nifedipine interaction: possible involvement of several mechanisms , 2005, Journal of clinical pharmacy and therapeutics.
[141] A. J. Campbell,et al. Pharmacokinetics of quinine in young and elderly subjects. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[142] D. Min,et al. Determination of Sildenafil Citrate in Plasma by High-Performance Liquid Chromatography and a Case for the Potential Interaction of Grapefruit Juice With Sildenafil Citrate , 2001, Therapeutic drug monitoring.
[143] P. Woster,et al. Bergamottin contribution to the grapefruit juice–felodipine interaction and disposition in humans , 2004, Clinical pharmacology and therapeutics.
[144] J. Oesterheld,et al. Grapefruit juice and clomipramine: shifting metabolitic ratios. , 1997, Journal of clinical psychopharmacology.
[145] D. Wortham,et al. Grapefruit Juice Alters the Systemic Bioavailability and Cardiac Repolarization of Terfenadine in Poor Metabolizers of Terfenadine , 1996, Journal of clinical pharmacology.
[146] R. Bergstrand,et al. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine — and its potential clinical relevance , 2004, European Journal of Clinical Pharmacology.
[147] Y. Sawada,et al. Effects of grapefruit juice and orange juice components on P‐glycoprotein‐ and MRP2‐mediated drug efflux , 2004, British journal of pharmacology.
[148] T. Nakanishi,et al. Species Difference in the Effect of Grapefruit Juice on Intestinal Absorption of Talinolol between Human and Rat , 2010, Journal of Pharmacology and Experimental Therapeutics.
[149] D. Bailey,et al. Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin , 1993, Clinical pharmacology and therapeutics.
[150] D. Min,et al. Effect of Grapefruit Juice on the Pharmacokinetics of Microemulsion Cyclosporine and its Metabolite in Healthy Volunteers: Does the Formulation Difference Matter? , 1998, Journal of clinical pharmacology.
[151] P. Neuvonen,et al. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice , 1995, Clinical pharmacology and therapeutics.
[152] U. Fuhr,et al. Grapefruit juice increases oral nimodipine bioavailability. , 1998, International journal of clinical pharmacology and therapeutics.
[153] C. DeVane,et al. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[154] D. Greenblatt. Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion‐Transporting Polypeptides , 2009, Journal of clinical pharmacology.
[155] F. Bernard,et al. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[156] D. Shen,et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.
[157] P. Coventry,et al. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. , 1994, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ).
[158] R. Kim,et al. Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.
[159] P. Gubbins,et al. Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. , 1999, Therapeutic drug monitoring.
[160] K. Sugawara,et al. The effects of grapefruit juice on the pharmacokinetics of erythromycin , 2001, European Journal of Clinical Pharmacology.
[161] S. Krähenbühl,et al. Interaction between grapefruit juice and midazolam in humans , 1995, Clinical pharmacology and therapeutics.
[162] R. Koopmans,et al. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. , 2002, The American journal of tropical medicine and hygiene.
[163] Y. Sawada,et al. Possible case of potentiation of the antiplatelet effect of cilostazol by grapefruit juice , 2007, Journal of clinical pharmacy and therapeutics.
[164] D. Bailey,et al. Grapefruit juice—felodipine interaction: Effect of naringin and 6′,7′‐dihydroxybergamottin in humans , 1998, Clinical pharmacology and therapeutics.
[165] Effects of Ingestion of Grapefruit Juice or Grapefruit on the Hypotensive Effect and Plasma Concentrations of Dihydropyridine Calcium Antagonists (Amlodipine and Nifedipine): A Case Study , 2010, Clinical and experimental hypertension.
[166] A. Mclean,et al. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. , 1995, British journal of clinical pharmacology.
[167] A. Muşmul,et al. Interaction between grapefruit juice and diazepam in humans , 2010, European Journal of Drug Metabolism and Pharmacokinetics.
[168] P. Neuvonen,et al. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin , 2000, Clinical pharmacology and therapeutics.
[169] C. Regårdh,et al. Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men , 1997, European Journal of Clinical Pharmacology.
[170] P. Neuvonen,et al. Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life , 2000, European Journal of Clinical Pharmacology.
[171] T. Ohta,et al. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[172] D. Min,et al. Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. , 1996, Transplantation.
[173] T. Hidaka,et al. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects. , 1998, International journal of clinical pharmacology and therapeutics.
[174] P. Pisarik. Blood pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a patient with severe renovascular hypertension. , 1996, Archives of family medicine.
[175] D. Min,et al. Effect of Grapefruit Juice on Pharmacokinetics of Microemulsion Cyclosporine in African American Subjects Compared with Caucasian Subjects: Does Ethnic Difference Matter? , 2001, Journal of clinical pharmacology.
[176] S. Mertens-Talcott,et al. Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. , 2006, Journal of agricultural and food chemistry.
[177] W. Lutz,et al. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[178] W. Tassaneeyakul,et al. Inhibition selectivity of grapefruit juice components on human cytochromes P450. , 2000, Archives of biochemistry and biophysics.
[179] R. Kim,et al. Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice , 2007, Clinical pharmacology and therapeutics.
[180] P Langguth,et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.
[181] W. Kirch,et al. Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects. , 2000, International journal of clinical pharmacology and therapeutics.
[182] M. Messenger,et al. Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[183] S. H. Lee,et al. Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability. , 2001, The Journal of clinical psychiatry.
[184] P. Hollenberg,et al. The Grapefruit Juice Effect Is Not Limited to Cytochrome P450 (P450) 3A4: Evidence for Bergamottin-Dependent Inactivation, Heme Destruction, and Covalent Binding to Protein in P450s 2B6 and 3A5 , 2005, Journal of Pharmacology and Experimental Therapeutics.
[185] C. Mckinstry,et al. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. , 1993, British journal of clinical pharmacology.
[186] P. Watkins,et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. , 2008, The American journal of clinical nutrition.
[187] K. Otani,et al. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam , 2000, Psychopharmacology.
[188] Wilhelm Kirch,et al. Grapefruit Juice Ingestion Significantly Reduces Talinolol Bioavailability , 2005, Clinical pharmacology and therapeutics.
[189] J. Spence,et al. Ethanol enhances the hemodynamic effects of felodipine. , 1989, Clinical and investigative medicine. Medecine clinique et experimentale.
[190] A. Boobis,et al. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice , 1997, European Journal of Clinical Pharmacology.
[191] C. Ducerf,et al. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade , 2007, European Journal of Clinical Pharmacology.
[192] M. V. van Agtmael,et al. Grapefruit juice increases the bioavailability of artemether , 1999, European Journal of Clinical Pharmacology.
[193] P. Neuvonen,et al. Effects of grapefruit juice on the pharmacokinetics of acebutolol. , 2005, British journal of clinical pharmacology.
[194] P. Dawson,et al. Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine , 2002, Clinical pharmacology and therapeutics.